How many years of comparable data are there for Pre-demographic dividend and Qatar?

30 years are reported by both, from 1990 to 2019.

Where does this data come from?

World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Pre-demographic dividend vs Qatar: Treatment for hypertension, male

Pre-demographic dividend

21.7%

in 2019

Qatar

47.8%

in 2019

Pre-demographic dividend rank

40th

Qatar rank

41st

Treatment for hypertension, male over time

Pre-demographic dividend
Qatar

How they compare

Qatar currently reports 47.8% against 21.7% in Pre-demographic dividend, a difference of 26.1%.

That makes Qatar's figure about 2.2 times Pre-demographic dividend's.

Across all 30 years both countries report, Qatar has been ahead every year.

Pre-demographic dividend ranks 40th and Qatar ranks 41st of 43 groups.

Qatar has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Pre-demographic dividend	Qatar	Difference	Ahead
1990s	7.1%	21.4%	14.2%	Qatar
2000s	11.1%	31.9%	20.8%	Qatar
2010s	17.8%	44.3%	26.4%	Qatar

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, male, Pre-demographic dividend or Qatar?: Qatar, at 47.8% against 21.7% in Pre-demographic dividend as of 2019.
What is the difference in treatment for hypertension, male between Pre-demographic dividend and Qatar?: 26.1%, with Qatar ahead.
How many years of comparable data are there for Pre-demographic dividend and Qatar?: 30 years are reported by both, from 1990 to 2019.
How do Pre-demographic dividend and Qatar rank globally for treatment for hypertension, male?: Pre-demographic dividend ranks 40th and Qatar ranks 41st of 43 groups.
Where does this data come from?: World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Pre-demographic dividend vs Qatar: Treatment for hypertension, male. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/pre-demographic-dividend/qatar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/pre-demographic-dividend/qatar/">Pre-demographic dividend vs Qatar: Treatment for hypertension, male</a> — Statizoid

About this data

Indicator: Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Unit: % of male adults ages 30-79 with hypertension
Source: World Health Organization's Global Health Observatory Data Repository
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 235 places, 7,050 data points, 1990–2019
Last refreshed: 17 September 2026

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.